| Literature DB >> 20352383 |
Jon H M Goosen1, Boudewijn J Kollen, René M Castelein, Bart M Kuipers, Cees C Verheyen.
Abstract
BACKGROUND: For total hip arthroplasty (THA), minimally invasive surgery (MIS) uses a smaller incision and less muscle dissection than the classic approach (CLASS), and may lead to faster rehabilitation. QUESTIONS/PURPOSES: Does minimally invasive hip arthroplasty result in superior clinical outcomes? PATIENTS AND METHODS: In this double-blind randomized controlled trial, 120 consecutive primary noncemented THAs in 120 patients were assigned to one of two groups (MIS or CLASS). The randomization sequence was stratified for two groups of surgeons, ie, those using a posterolateral approach (PL-CLASS or PL-MIS) and those using an anterolateral approach (AL-CLASS or AL-MIS). Length of the incisions was 18 cm for the CLASS procedures. MIS incisions were extended at the skin level to 18 cm at the end of the procedure. The primary end point was the Harris hip score (HHS) at 6 weeks postoperatively. Patient-centered questionnaires were obtained preoperatively and after 6 weeks and 1 year.Entities:
Mesh:
Year: 2010 PMID: 20352383 PMCID: PMC3008875 DOI: 10.1007/s11999-010-1331-7
Source DB: PubMed Journal: Clin Orthop Relat Res ISSN: 0009-921X Impact factor: 4.176
Fig. 1The trial profile is shown in this diagram. BMI = body mass index; MIS = minimally invasive surgery; AL-MIS = anterolateral MIS; PL-MIS = posterolateral MIS; CLASS = classic approach; AL-CLASS = anterolateral CLASS; PL-CLASS = posterolateral CLASS.
Demographic characteristics
| Parameter | Approach | p Value | |
|---|---|---|---|
| MIS | Classic | ||
| Hips (n) | 60 30–30 | 60 30–30 | |
| Gender (n) | |||
| Male | 30 15–15 | 29 13–16 | 1.0a .89a |
| Female | 30 15–15 | 31 17–14 | |
| Height in m (SD) | 1.73 (0.07) 1.72 (0.06)–1.74 (0.08) | 1.73 (0.08) 1.73 (0.07)–1.73 (0.09) | .94b .89c |
| Weight in kg (SD) | 79.5 (11.0) 78 (9.8)–81 (12.1) | 79.3 (11.9) 80 (9.2)–78 (14.2) | .93b .80c |
| Body Mass Index (SD) | 26.6 (2.8) 26.4 (2.6)–26.7 (3.1) | 26.4 (2.8) 26.8 (2.7)–26.1 (2.8) | .80b .74c |
| Age at operation in years (SD) | 60 (6.8) 60 (6.3)–60 (7.4) | 62 (6.6) 62 (6.3)–62 (6.9) | .13b .51c |
| Preoperative diagnosis (n) | |||
| Osteoarthritis | 55 27–28 | 59 29–30 | .32a .45a |
| Osteonecrosis | 1 0–1 | 0 | |
| Developmental dysplasia | 2 2–0 | 1 1–0 | |
| Posttrauma | 2 1–1 | 0 | |
| Side (n) | |||
| Right | 39 20–19 | 36 18–18 | .57a .94a |
| Left | 21 10–11 | 24 12–12 | |
1posterolateral; 2anterolateral; achi square test; bindependent Student t-test; cone-way ANOVA with Bonferroni correction.
Preoperative and directly postoperative results
| Parameter | Approach | p Value | |
|---|---|---|---|
| Groin circumference (cm) (SD) | MIS PL1–AL2 | Classic PL1–AL2 | .34a .68b |
| Operation time (minutes) (SD) | < .001a† .004b†† | ||
| Preoperative incision length (cm) | |||
| Hip in flexion (SD) | 7.8 (1.4) 7.7 (1.4)–8.0 (1.5) | 18 | < .001a† |
| Hip in extension (SD) | 7.8 (1.6) 7.8 (1.5)–7.8 (1.5) | 18 | < .001a† |
| Postoperative incision length (cm) | |||
| Hip in flexion (SD) | 8.5 (1.9) 8.6 (2.3)–8.4 (1.5) | 18 | < .001a† |
| Hip in extension (SD) | 8.4 (2.0) 8.6 (2.3)–8.2 (1.6) | 18 | < .001a† |
| Perioperative blood loss (mL) (SD) | 540 (321) 579 (362)–500 (273) | 490 (228) 452 (163)–532 (279) | .34a .36b |
| Hemoglobin (mmol/L) | |||
| Preoperative | 9.0 (0.8) 9.0 (0.8)–8.9 (0.7) | 8.8 (0.7) 8.8 (0.8)–8.9 (0.7) | .37a .71b |
| Postoperative | 6.9 (0.8) 6.8 (0.8)–6.9 (0.7) | 6.7 (0.9) 6.8 (0.9)–6.7 (0.9) | .34a .71b |
| Creatine kinase (IU/L) | |||
| Preoperative | 101 (65) 98 (34)–105 (89) | 103 (45) 102 (48)–104 (43) | .85a .97b |
| Postoperative | 485 (285) 503 (241)–464 (336) | 466 (295) 441 (343)–495 (233) | .75a .88b |
| Myoglobin (μ/L) | |||
| Preoperative | 37 (10) 34 (6)–39 (12) | 37 (10) 38 (13)–37 (7) | .70a .40b |
| Postoperative | 195 (153) 170 (127)–222 (175) | 190 (107) 148 (83)–235 (113) | .87a .09b |
1posterolateral; 2anterolateral; aindependent Student t-test; bone-way ANOVA with Bonferroni correction; †statistically significant; ††statistically significant: PL-MIS and AL-MIS vs PL-CLASS and AL-CLASS.
Clinical results
| Scoring system | Approach | p Valuea | |
|---|---|---|---|
| MIS | Classic | ||
| Harris Hip Score (SD) | |||
| Preoperative | 58 (16) 60 (16)–56 (15) | 57 (12) 57 (13)–57 (12) | .69a .65b |
| 6 weeks | 77 (12) 80 (10) -73 (13) | 72 (13) 70 (15)–75 (15) | .03a† .009b†† |
| 1 year | 94 (8) 97 (4)–91 (10) | 90 (10) 90 (10)–90 (10) | .03a† .013b†† |
| WOMAC (SD) | |||
| Preoperative | 47 (14) 50 (12)–46 (16) | 48 (15) 48 (17)–48 (13) | .87a .76b |
| 6 weeks | 69 (16) 69 (18)–69 (12) | 72 (15) 71 (16)–73 (14) | .32a .73b |
| 1 year | 82 (18) 80 (22)–84 (13) | 81 (16) 79 (19)–82 (12) | .71a .75b |
| OHS (SD) | |||
| Preoperative | 40 (9) 39 (8)–42 (9) | 40 (8) 40 (9)–40 (7) | .98a .79b |
| 6 weeks | 36 (9) 34 (8)–37 (9) | 36 (12) 36 (11)–37 (13) | .66a .62b |
| 1 year | 24 (15) 26 (19)– 21 (8) | 25 (12) 27 (14)–23 (7) | .81a .38b |
| SF-36 (SD) | |||
| Preoperative | 56 (15) 60 (15)–53 (14) | 58 (14) 58 (15)–58 (14) | .50a .31b |
| 6 weeks | 67 (14) 71 (12)–63 (15) | 61 (16) 61 (15)–62 (17) | .03a† .04b†† |
| 1 year | 80 (19) 81 (15)–79 (23) | 80 (16) 75 (20)–86 (7) | .99a .11b |
1posterolateral; 2anterolateral; aindependent Student t-test; bone-way ANOVA with Bonferroni correction; †statistically significant; ††statistically significant: PL-MIS vs AL-MIS, PL-CLASS and AL-CLASS.
Clinical results*
| Complications | Approach | p Valuea | |
|---|---|---|---|
| MIS | Classic | ||
| Preoperative | 6 2–4 | 2 0–2 | .08 .24 |
| Proximal femoral fracture | 4 0–4 | 2 0–2 | .34 .05 |
| Massive venous bleeding | 1 1–0 | 0 | |
| Sciatic nerve palsy | 1 1–0 | 0 | |
| Postoperative | |||
| Infection | 0 | 1 0–1 | |
| Aseptic loosening after component revision | 4 0–4 | 2 1–1 | .34 .10 |
| Cup revision | 0 | 1 1–0 | |
| Stem revision | 4 0–4 | 1 0–1 | .36 .11 |
* Based on HHS, WOMAC, OHS, and SF-36 scores; 1posterolateral; 2anterolateral; aFisher’s exact test.
Radiographic measures
| Radiographic measures | Approach | p Value | |
|---|---|---|---|
| MIS | Classic | ||
| Stem alignment (°) (SD) | 2 (2) 3 (2)–1 (2) | 2 (2) 2 (2)–2 (2) | .72a .08b |
| Cup inclination (°) (SD) | 47 (9) 50 (9)–45 (9) | 47 (7) 50 (6)–43 (6) | .55a < .001b†† |
| Grading of inclination (Sarmiento) (%) | |||
| Grade 1 | 6 (10) 2 (7)–4 (14) | 4 (7) 0–4 (14) | .49c .18c |
| Grade 2 | 41 (68) 21 (70)–20(70) | 49 (82) 25 (83)–24 (80) | .08c .39c |
| Grade 3 | 12 (20) 7 (23)–5 (16) | 6 (10) 5 (17)–1 (6) | .13c .17c |
| Leg length discrepancy (mm) (SD) | 0.1 (8) 1.5 (7)–1.3 (9) | −0.5 (6) −0.5 (6) – 0.5 (7) | .64a .47b |
| Periarticular ossification (Brooker) (%) | |||
| Grade 1 | 11 (18) 3 (10)–8 (27) | 8 (13) 4 (13)–4 (13) | .31c .27c |
| Grade 2 | 3 (5) 1 (3)–2 (6) | 2 (3) 0–2 (6) | .50c .49c |
| Grade 3 | 0 | 3 (5) 0–3 (10) | .12c .02c† |
1posterolateral; 2anterolateral; aindependent Student t-test; bone-way ANOVA with Bonferroni correction; cchi square test; †statistically significant; ††statistically significant PL-MIS vs AL-CLASS and PL-CLASS vs AL-CLASS.